# Preoperative Tamsulosin to Prevent Postoperative Urinary Retention After Surgery For Pelvic Floor Disorders

> **NCT04232683** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **The Cleveland Clinic** · enrollment: 100 (actual)

## Conditions studied

- Urinary Retention

## Interventions

- **DRUG:** Tamsulosin 0.4Mg Capsule
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04232683
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-12-18
- **Primary completion:** 2025-10-11
- **Final completion:** 2025-12
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04232683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04232683, "Preoperative Tamsulosin to Prevent Postoperative Urinary Retention After Surgery For Pelvic Floor Disorders". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04232683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*